Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: the OPTIPARK open-label study.
Heinz ReichmannAndrew LeesJosé-Francisco RochaDiogo MagalhãesPatricio Soares-Da-Silvanull nullPublished in: Translational neurodegeneration (2020)
Registered in July 2016 at clinicaltrials.gov (NCT02847442).